Rosuvastatin 20 mg film-
Sponsors
International Bio Service Co., Ltd., International Bio Service Co. Ltd, Bio-innova and Synchron.Co.,Ltd
Conditions
Bioequivalence Study,Bioequivalence study
Bioequivalence study
RosuvastatinHealthy volunteers
Rosuvastatin, Bioequivalence Study, Healthy Thai Volunteer
Phase 1
Bioequivalence Study of 20 mg Rosuvastatin Film-coated Tablets in Healthy Thai Volunteers
Active, not recruitingTCTR20180725005
Start: 2018-09-17Target: 32Updated: 2026-03-30
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Rosuvastatin 20 mg Film-coated Tablet and Reference Product (CRESTOR 20 mg) in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20200322001
Start: 2020-05-01Target: 34Updated: 2026-03-30
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Rosuvastatin 20 mg film-coated tablets relative to Crestor 20 mg tablets in healthy Thai volunteers under fasting condition
Active, not recruitingTCTR20200617004
Start: 2020-09-08Target: 36Updated: 2026-03-30